Arrowstreet Capital Limited Partnership Has $72.52 Million Holdings in Envista Holdings Corporation $NVST

Arrowstreet Capital Limited Partnership raised its holdings in Envista Holdings Corporation (NYSE:NVST) by 341.5% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,858,293 shares of the company’s stock after buying an additional 2,210,847 shares during the quarter. Arrowstreet Capital Limited Partnership’s holdings in Envista were worth $72,515,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of NVST. Tudor Investment Corp ET AL bought a new stake in Envista in the third quarter valued at $1,664,000. Massachusetts Financial Services Co. MA boosted its position in shares of Envista by 15.3% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 3,349,874 shares of the company’s stock worth $72,726,000 after purchasing an additional 444,725 shares in the last quarter. Royce & Associates LP grew its stake in shares of Envista by 11.6% in the 4th quarter. Royce & Associates LP now owns 996,147 shares of the company’s stock valued at $21,626,000 after buying an additional 103,312 shares during the period. Jackson Creek Investment Advisors LLC acquired a new stake in shares of Envista in the 4th quarter valued at about $1,447,000. Finally, Intech Investment Management LLC bought a new stake in Envista in the 4th quarter valued at about $2,501,000.

Envista Stock Up 0.1%

NVST stock opened at $26.34 on Monday. Envista Holdings Corporation has a twelve month low of $18.77 and a twelve month high of $30.42. The company has a quick ratio of 2.06, a current ratio of 2.44 and a debt-to-equity ratio of 0.47. The stock’s 50 day moving average is $25.19 and its 200-day moving average is $25.77. The firm has a market capitalization of $4.29 billion, a PE ratio of 64.26, a P/E/G ratio of 1.49 and a beta of 0.86.

Envista (NYSE:NVST) last announced its earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.05. Envista had a return on equity of 7.11% and a net margin of 2.41%.The company had revenue of $705.50 million for the quarter, compared to analysts’ expectations of $680.03 million. During the same quarter in the previous year, the firm earned $0.24 earnings per share. Envista’s quarterly revenue was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Sell-side analysts expect that Envista Holdings Corporation will post 1.42 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently weighed in on NVST shares. BMO Capital Markets began coverage on Envista in a research note on Wednesday, July 8th. They set a “market perform” rating and a $27.00 price target on the stock. Evercore restated an “outperform” rating and set a $33.00 price objective on shares of Envista in a report on Thursday, May 7th. Robert W. Baird lifted their price target on shares of Envista from $30.00 to $31.00 and gave the company an “outperform” rating in a research report on Thursday, May 7th. JPMorgan Chase & Co. boosted their price target on shares of Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Finally, Weiss Ratings downgraded shares of Envista from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Six investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $28.54.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.